William Sanger

Chairman

Mr. Sanger has provided leadership to the health care industry for over 30 years and is also currently the Chairman and CEO of Emergency Medical Services Corporation (NYSE;EMS). He has successfully led multi-system hospitals, including ambulatory care, post-acute services (nursing homes), physician management companies, freestanding diagnostic and treatment centers, and managed care entities. Mr. Sanger co-founded a publicly traded health care company and established one of the first managed care organizations. His expertise in strategic positioning for health care entities is nationally renowned. He has provided turnaround and merger and acquisition (M&A) consultation to private, publicly traded, and not-for-profit domestic and international health care companies.

 

Wilson Allen

Mr. Allen is currently a Managing Director of Westlake Securities, an Austin, Texas-based investment bank that serves the middle market with an emphasis for regional corporations and emerging companies. Since 1995, he has provided leadership and guidance to early-stage companies with unique intellectual property in large markets, assisting with capital, corporate structure, strategy, and developing management teams. Prior to 1995, he served as senior equity trader and member of the asset allocation group for a $2 billion money management firm, Eagle Management. He has served on numerous for profit and non-profit Boards throughout his career. Mr. Allen earned a BA from the University of Texas and an MBA from Pepperdine University.

 

James M. Kenny

Mr. Kenny is currently a managing partner of Voltron Ventures, a venture capital firm specializing in high tech/med tech investments. Mr. Kenny has been involved in private equity ventures and investments for the last ten years and previously served as vice president of Signature Capital. At Signature Capital, he was involved in the formation and funding of several start-up companies, including Additch, Acoustic Technologies, NetNumber and VIR xSYS. Most recently, Mr. Kenny co-founded and serves on the board of directors of Quickfilter Technologies, a fabless semiconductor company specializing in programmable digital filters for signal processing. Mr. Kenny received a BA and MBA from Georgetown University. He serves on the board of regents for Georgetown University and on the board of directors for the NYU Cancer Center.

 

Jack McMullen

Mr. McMullen is currently the Managing Principal of Cambridge Meridian Group, Inc., a strategy-consulting firm that serves Fortune 500 and technology-based companies. Mr. McMullen previously taught business strategy at Harvard Law School. He serves, or has served, on the Boards of three NASDAQ -listed technology companies as well as 12 other privately funded, chiefly technology-oriented companies. From 1993 to 1997 he was an informal advisor to Senator Bradley (D-NJ). In 2004 he was the Republican nominee for the United States Senate from Vermont. He is a Navy veteran who served on the staff of Admiral Rickover overseeing the retrofit of advanced technology reactors into the Navy’s nuclear fleet. He is a Phi Beta Kappa graduate of Columbia University in Applied Physics and Engineering and received a JD with Honors from Harvard Law School and an MBA with High Distinction from Harvard Business School, where he was elected a First Year Baker Scholar.

 

Robert G. Shepler

Mr. Shepler is currently a Managing Director of Telegraph Hill Partners, a private equity firm focused on medical devices, life science technology and health care companies. Mr. Shepler has been an investor and corporate transactions specialist for 30 years. He has served on numerous company boards and completed over 150 M&A and financing transactions. P rior to forming Telegraph Hill’s predecessor firm in 1991, he was an officer with Merrill Lynch in their corporate finance division. In addition to Vidacare, his current directorships include Estech, Applied Precision, and LDR Spine.

 

Harold L. Timboe, MD, MPH

Dr. Timboe is currently a family physician and physician executive. A Vietnam and Gulf War I veteran, he retired in 2002 as a Major General from the US Army after a distinguished career culminating as commander of Walter Reed Army Medical Center in Washington, DC. He has extensive experience in executive leadership of large, complex health systems, senior health policy positions, and is a decorated combat medical leader with several experiences in mass casualty situations and natural disasters, including the 9/11 Pentagon attack, anthrax letters, Indonesian tsunami, Hurricane Katrina, and the Haitian earthquake. After military service, he served for five years at his medical alma mater, The University of Texas Health Science Center at San Antonio as an Associate Vice President, Clinical Professor and Director, Center for Public Health Preparedness. General Timboe is a graduate of the United States Military Academy at West Point and the Army War College. He also has a Masters of Public Health from the University of Hawaii, and holds positions on the boards of several private companies as well as non-profit organizations. Harold and his wife, Donna, live in Bentonville, Arkansas, near their children and grandchildren, where he is a member of the Executive Council of the Soderquist Center for Leadership and Ethics.

 

James Tullis

Mr. Tullis is currently the founder and chief executive officer of Tullis Health Investors, a health care venture capital firm based in Stamford, Connecticut. Under his direction, the firm has invested in a portfolio of companies representing innovative concepts in pharmaceuticals, biotechnology, managed care, health insurance, health care information technology, logistics and distribution, and medical devices. Prior to establishing Tullis Health Investors in 1986, Jim worked as an analyst at Morgan Stanley where he managed health care investment research, focusing on pharmaceuticals and medical devices. During his tenure on Wall Street, he received many accolades, including recognition on the Institutional Investor All-Star list of Wall Street’s top securities analysts. He was twice named #1 Drug Analyst, was featured on the Wall Street Week television program, and authored Wall Street’s first research report on biotechnology. Jim is a graduate of Stanford University and earned an MBA from Harvard Business School. He currently serves on the Boards of several public and private companies.